ADR MONITORING IN HYPERTENSION OUT PATIENT DEPARTMENT OF HOSPITAL
Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2013, Vol 1, Issue 2
Abstract
Adverse drug reactions (ADRs) to anti-hypertensive agents are common and can lead to noncompliance or even discontinuation of therapy. There is paucity of such data in the Indian context. We deemed it worthwhile to assess the suspected ADR profile of anti-hypertensive drugs in an ambulatory setting in a public teaching hospital. A longitudinal observational study was conducted in the outpatient department (OPD) of the concerned unit. Twenty consecutive patients per day, irrespective of their hypertensive diagnosis, were screened for suspected ADRs, 2 days in a week, over 6 months. Adverse event history, medication history and other relevant details were captured in a format as adopted. We screened 2000 patients (68.69% males, median age 38 years), of whose 429 were suspected of having at least one ADR; 84 cases had insufficient evidence about causality and were excluded from further analysis. Thus, 17.25% (95% confidence interval: 15.59-18.91%) of our study population reported ADRs with at least “possible” causality. Of 352 events recorded, 327 (92.90%) were “probable” and the rest “possible”. None was labeled “certain” as re-challenge was not performed. Patients received a median of 3.2 anti-hypertensive drugs each. Thirty-three different kinds of ADRs were noted, including tremor (19.60%), weight gain (15.34%) and constipation (14.49%). Among the incriminated drugs, anti-hypertensive represented the majority (57.10%) of the list. This study offers a representative profile of ADRs to be expected in anti-hypertensive out-patients in an Indian public hospital. Establishment of an anti-hypertensive drug ADR database can be a worthy longterm goal in the Indian context.
Authors and Affiliations
Sreenu Thalla, K. Venkatta Ramana, Sk. Sheherbanu, Sk. Ashya, A. Manikanteswara Reddy, B. Lakshmi
Keywords
Related Articles
- EP ID EP33049
- DOI -
- Views 354
- Downloads 0
RP-HPLC DEVELOPMENT AND VALIDATION OF ASSAY AND UNIFORMITY OF DOSAGE UNITS BY CONTENT UNIFORMITY FOR IN HOUSE LAMIVUDINE AND ABACAVIR COMBINED TABLET
A precise, accurate, highly sensitive, rugged and robust HPLC method has been developed and validated for the assay and content uniformity of Lamivudine and Abacavir in combined tablets. The method was developed using...
Formulation development and evaluation of matrix tablets of propranolol HCl by using release retarding agents
The main aim of the present work is to formulate and develop matrix tablets of Propranolol HCl. Selected suitable method for preparation process of Direct compression method for matrix tablets of Propranolol HCl by usi...
Drug therapy problems and contributing factors among patients with cardiovascular diseases in Felege Hiwot Referral and Jimma University Specialized Hospital, Ethiopia
Drug therapy problem is a new concept developed around 1990s. It results in increased morbidity and mortality. Although pharmacotherapy in cardiovascular diseases can improve patient outcome, its benefit can be comprom...
Toxicity and Environmental Risks of Nanomaterials: Challenges and Future Needs
Nanotechnology has gained a great interest due to the needs and applications of nanomaterials in many areas including agriculture, industry, medicine business and public health. The increase in the use of nanomaterials...
A review on the use of Bleomycin-Cisplatin-Vinblastine combinations in therapy of testicular cancer
Combination chemotherapy with vinblastine plus bleomycin in disseminated testicular cancer was pioneered by Samuels and represented a major therapeutic advance (Samuels ML, 1976). Another milestone in the chemotherapy...